News|Articles|May 6, 2022

NeurologyLive® Friday 5 — May 6, 2022

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending May 6, 2022.

Welcome to NeurologyLive®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Mind Moments Ep. 63: Moving Migraine Toward Personalized Care

Episode 63 Mind Moments™, a podcast from NeurologyLive®, brings you an exclusive interview with Jessica Ailani, MD, who spoke about some recent data in headache medicine that has provided evidence of the in-clinic experience and how the migraine treatment landscape has shifted almost continuously in the past several years.

2: Peers & Perspectives: Novel Treatment Options for the Management of Narcolepsy

In Episode 11 of this NeurologyLive® Peers & Perspectives series "Improving Diagnosis and Patient Outcomes in Narcolepsy," Margaret Park, MD, and Russell Rosenberg, PhD, DABSM, provide insight on novel FDA-approved treatment options and their impact on the narcolepsy treatment landscape.

3: FDA Action Update, April 2022: Extensions, Approvals, and Designations

Catch up on any of the neurology news headlines you may have missed over the course of the last month, compiled all into one place by the NeurologyLive® team.

4: Peer Exchange: Using Diagnostic Tools to Assess Migraine

In Episode 5 of this NeurologyLive® Peer Exchange™ series, "Improving Diagnosis and Patient Outcomes in Narcolepsy," experts in migraine care, Julio R. Vieira, MD; Jessica Ailani, MD; and Bradley Torphy, MD, review diagnostic tools available for migraine, including patient use of headache diaries.

5: Weighing Approaches on Preventive Use, Medication Overuse in Chronic Migraine: Vincent Martin, MD

The president of the National Headache Foundation discussed whether switching or continuing preventive medications has a benefit in patients who have chronic migraine with medication overuse.

—————————————————

Newsletter

Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.

Latest CME